Standout Papers
Citation Impact
Citing Papers
Enterococcus faecalis Infective Endocarditis
2013
HIV controllers exhibit potent CD8 T cell capacity to suppress HIV infection ex vivo and peculiar cytotoxic T lymphocyte activation phenotype
2007 StandoutNobel
Empiric Combination Antibiotic Therapy Is Associated with Improved Outcome against Sepsis Due to Gram-Negative Bacteria: a Retrospective Analysis
2010
Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society
2016 Standout
Are healthcare workers’ intentions to vaccinate related to their knowledge, beliefs and attitudes? a systematic review
2013 Standout
Gender differences in depression in representative national samples: Meta-analyses of diagnoses and symptoms.
2017 Standout
Retroviral superinfection resistance
2005
A cell-free platform for the prenylation of natural products and application to cannabinoid production
2019 StandoutNobel
Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications
2015 Standout
Leishmaniasis
2018 Standout
Estimation of HIV Incidence in the United States
2008 Standout
Lyme Disease
1989 Standout
Recapitulation of the hepatitis C virus life-cycle in engineered murine cell lines
2013 StandoutNobel
Hepatitis C Virus Infection
2001 Standout
Effect of Adequate Single-Drug vs Combination Antimicrobial Therapy on Mortality in Pseudomonas aeruginosa Bloodstream Infections: A Post Hoc Analysis of a Prospective Cohort
2013
Hepatitis C and human immune deficiency coinfection at the era of highly active antiretroviral therapy
2002
Association of hepatitis C virus envelope proteins with exosomes
2004 StandoutNobel
Immunologic correlates of protection induced by vaccination
2001
Impact of adequate empirical combination therapy on mortality from bacteremic Pseudomonas aeruginosapneumonia
2012
The clinical utility of viral quantitation using molecular methods
1998
Meta-Analysis of High-Risk Sexual Behavior in Persons Aware and Unaware They are Infected With HIV in the United States
2005 Standout
The Epidemiological Profile of Infections with Multidrug-Resistant Pseudomonas aeruginosa and Acinetobacter Species
2006
Evaluating the impact of an educational intervention to increase CRC screening rates in the African American community: a preliminary study
2010
European Lyme Borreliosis
1988
Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance
2011 Standout
Trends in GPCR drug discovery: new agents, targets and indications
2017 Standout
Drug-Induced Hepatotoxicity
2003 Standout
Coinfection of Hepatitis C Virus with Human Immunodeficiency Virus and Progression to AIDS
1995
Increasing Mortality Due to End-Stage Liver Disease in Patients with Human Immunodeficiency Virus Infection
2001
Hepatitis C virus-associated hepatitis following treatment of HIV-infected patients with HIV protease inhibitors
1998
Quantitative PCR and RT-PCR in virology.
1993
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
2008 Standout
Severe Sepsis and Septic Shock
2013 Standout
A survival benefit of combination antibiotic therapy for serious infections associated with sepsis and septic shock is contingent only on the risk of death: A meta-analytic/meta-regression study
2010
Lyme Carditis: An Important Cause of Reversible Heart Block
1989
Diagnosis, management, and treatment of hepatitis C: An update # † ‡
2008 Standout
Novel Antibiotic Combinations against Infections with Almost Completely Resistant Pseudomonas aeruginosa and Acinetobacter Species
2006
Is HIV a Model of Accelerated or Accentuated Aging?
2013
Optimal management therapy for Pseudomonas aeruginosa ventilator-associated pneumonia: An observational, multicenter study comparing monotherapy with combination antibiotic therapy*
2007
CD4 T Lymphocyte Proliferative Responses to Hepatitis C Virus (HCV) Antigens in Patients Coinfected with HCV and Human Immunodeficiency Virus Who Responded to Anti‐HCV Treatment
2002 StandoutNobel
Influence of microbial infections on the progression of HIV disease
1997 StandoutNobel
Estimating sexual transmission of HIV from persons aware and unaware that they are infected with the virus in the USA
2006 Standout
Reciprocal Interactions Between Human Immunodeficiency Virus and Hepatitis C Virus Infections
1996
Interventions for improving the adoption of shared decision making by healthcare professionals
2010
Microbial Etiologies of Hospital‐Acquired Bacterial Pneumonia and Ventilator‐Associated Bacterial Pneumonia
2010
Early and Late Cutaneous Manifestations in Ixodes‐borne Borreliosis (Erythema Migrans Borreliosis, Lyme Borreliosis)a
1988
Mumps Outbreaks in Vaccinated Populations: Are Available Mumps Vaccines Effective Enough to Prevent Outbreaks?
2008
Fluoroquinolone-Resistant Pseudomonas aeruginosa: Assessment of Risk Factors and Clinical Impact
2006
Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance
2009 StandoutNature
Global epidemiology of HIV infection in men who have sex with men
2012 Standout
The pathogenesis ofLeishmania/HIV co-infection: cellular and immunological mechanisms
2003
Stress-induced immune dysfunction: implications for health
2005 Standout
The spatial distribution of Borrelia burgdorferi-infected Ixodes ricinus in the Connemara region of County Galway, Ireland
1995
Hospital-Acquired Infections Due to Gram-Negative Bacteria
2010 Standout
Geroscience: Linking Aging to Chronic Disease
2014 Standout
Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection†‡
2006 Standout
Heterologous Epitope-Scaffold Prime∶Boosting Immuno-Focuses B Cell Responses to the HIV-1 gp41 2F5 Neutralization Determinant
2011 StandoutNobel
Hepatitis C Virus (HCV) Viremia in Human Immunodeficiency VirusSeronegative and -Seropositive Patients with Indeterminate HCV Recombinant Immunoblot Assay
1994
HIV transmission risk through anal intercourse: systematic review, meta-analysis and implications for HIV prevention
2010
Piperacillin-Tazobactam for Pseudomonas aeruginosa Infection: Clinical Implications of an Extended-Infusion Dosing Strategy
2007
Pharmacodynamic comparisons of antimicrobials against nosocomial isolates of escherichia coli, klebsiella pneumoniae, acinetobacter baumannii and pseudomonas aeruginosa from the MYSTIC surveillance program: the OPTAMA Program, South America 2002
2004
Lyme borreliosis
2011 Standout
Risk factors for multidrug-resistant Pseudomonas aeruginosa acquisition. Impact of antibiotic use in a double case–control study
2009
Lyme borreliosis in Europe and North America
2004
Barriers and facilitators to implementing shared decision-making in clinical practice: a systematic review of health professionals' perceptions
2006
Clinical Evaluation of Branched DNA Signal Amplification for Quantifying HIV Type 1 in Human Plasma
1995
Second-stage non-response in the Swiss health survey: determinants and bias in outcomes
2013
Myocarditis
2009 Standout
Replication of hepatitis C virus
2007 StandoutNobel
Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management
2015 Standout
Acinetobacter baumannii : Emergence of a Successful Pathogen
2008 Standout
HIV-1 Dynamics in Vivo: Virion Clearance Rate, Infected Cell Life-Span, and Viral Generation Time
1996 StandoutScience
Enhanced SARS-CoV-2 neutralization by dimeric IgA
2020 StandoutNobel
Dynamics of molecular parameters of human immunodeficiency virus type 1 activity in vivo
1994
Carbapenemases: the Versatile β-Lactamases
2007 Standout
Rational HIV Immunogen Design to Target Specific Germline B Cell Receptors
2013 StandoutScienceNobel
Hepatitis C in the HIV-Infected Person
2003
Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America
2011 Standout
The MIQE Guidelines: Minimum Information for Publication of Quantitative Real-Time PCR Experiments
2009 Standout
β-Lactam and Fluoroquinolone Combination Antibiotic Therapy for Bacteremia Caused by Gram-Negative Bacilli
2009
Decision aids for people facing health treatment or screening decisions
2017 Standout
Combination antibiotic therapy versus monotherapy for Pseudomonas aeruginosa bacteraemia: A meta-analysis of retrospective and prospective studies
2013
Phylogeny of hard- and soft-tick taxa (Acari: Ixodida) based on mitochondrial 16S rDNA sequences.
1994 Standout
Screening for Hepatitis C Virus in Human Immunodeficiency Virus-Infected Individuals
2000
Patients’ Expectations of the Benefits and Harms of Treatments, Screening, and Tests
2014
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
2008 Standout
Viral dynamics in human immunodeficiency virus type 1 infection
1995 StandoutNature
Response of Hepatitis C Virus to Long-Term Passage in the Presence of Alpha Interferon: Multiple Mutations and a Common Phenotype
2013 StandoutNobel
Real time quantitative PCR.
1996 Standout
Investigation of the validity of species status of Ixodes dammini (Acari: Ixodidae) using rDNA.
1993
2015 ESC Guidelines for the management of infective endocarditis
2015 Standout
Sativex ® as add-on therapy vs. further optimized first-line ANTispastics (SAVANT) in resistant multiple sclerosis spasticity: a double-blind, placebo-controlled randomised clinical trial
2018
Nonresponse Rates and Nonresponse Bias in Household Surveys
2006 Standout
Evidence for the efficacy and effectiveness of THC-CBD oromucosal spray in symptom management of patients with spasticity due to multiple sclerosis
2015
Combination Therapy for Treatment of Infections with Gram-Negative Bacteria
2012
Biological variation and quality control of plasma human immunodeficiency virus type 1 RNA quantitation by reverse transcriptase polymerase chain reaction
1993
Correlates of Protection Induced by Vaccination
2010 Standout
Works of Eric Chamot being referenced
Effectiveness of Combination Antimicrobial Therapy for Pseudomonas aeruginosa Bacteremia
2003
Association between Vancomycin-Resistant Enterococci Bacteremia and Ceftriaxone Usage
2012
Importance of patients’ perceptions and general practitioners’ recommendations in understanding missed opportunities for immunisations in Swiss adults
2001
Influence of Previous Exposure to Antibiotic Therapy on the Susceptibility Pattern ofPseudomonas aeruginosaBacteremic Isolates
2001
Loss of antibodies against hepatitis C virus in HIV-seropositive intravenous drug users
1990
Nonresponse Bias in a Survey of Patient Perceptions of Hospital Care
2005
Predicting stages of adoption of mammography screening in a general population
2001
Natural History of Multiple Sclerosis Symptoms
2013 Standout
Misconceptions about efficacy of mammography screening: a public health dilemma
2001
Gonorrhea incidence and HIV testing and counseling among adolescents and young adults seen at a clinic for sexually transmitted diseases
1999
Perceived stress, internal resources, and social support as determinants of mental health among young adults
2004
Multimorbidity Patterns in HIV-Infected Patients
2012
Quantitation of Human Immunodeficiency Virus Provirus and Circulating Virus: Relationship with Immunologic Parameters
1992
Impact of small reductions in plasma HIV RNA levels on the risk of heterosexual transmission and disease progression
2008
B. burgdorferi in Switzerland
1987
Women’s Preferences for Doctor’s Involvement in Decisions about Mammography Screening
2004
[Enlarged spectrum of tick transmitted spirochaetoses].
1986
[Acute auriculo-ventricular block associated with Lyme disease. A case confirmed by serology].
1985
[Estimation of the efficacy of three strains of mumps vaccines during an epidemic of mumps in the Geneva canton (Switzerland)].
1998